Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

Regulus Therapeutics Inc. Stock

Price
Target price
-

-

-
-
-
?9.22

?9.22

 
Buy 3 Sell 2
Buy 3
Sell 2
WKN: A3DNZ4 / Symbol: RGLS / Name: Regulus Therapeutics / Stock / Micro Cap /
Latest predictions
23.06.25
-0.71%
buy
18.05.25
0.00%
sell
10.05.25
-2.76%
sell
€5.57
27.03.25
373.15%
buy
€9.22
14.03.25
414.60%
buy
Show more
Best running prediction
€9.22
14.03.25
414.60%
buy
Your prediction
Pros and Cons of Regulus Therapeutics Inc. in the next few years
Wizard

Regulus Therapeutics Inc. Stock

Based on 3 Buy predictions and 2 Sell predictions the sentiment towards Regulus Therapeutics Inc. is rather balanced.
With a target price of 9 € there is a positive potential of 27.66% for Regulus Therapeutics Inc. compared to the current price of 7.05 €.
Our community identified positive and negative aspects for Regulus Therapeutics Inc. stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Regulus Therapeutics Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
What does Regulus Therapeutics do?

Pros and Cons of Regulus Therapeutics Inc. in the next few years

Pros
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

Regulus Therapeutics Inc. (RGLS) presents a complex picture when analyzing its financial statements and ratios. The company, which operates in a pioneering and volatile sector — biotechnology — has been navigating the challenging landscape of drug development. Overall, the financials reveal potential red flags, but also some aspects that merit further exploration. Let’s take a deeper dive into the various components.

Pros of Regulus Therapeutics’ Financials

Market Capitalization: With a market capitalization of approximately $109.3 million, Regulus Therapeutics remains within a reasonable range for biotech firms. A stable market cap can often indicate foundational support, which is essential as the company develops its products and strategies.

Show more

Comments

Regulus Therapeutics Inc. (NASDAQ: RGLS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for RGLS provided by MarketBeat
Show more

StockNews.com 
0
Report Share
18.05.25 Sell 0.00%

Regulus Therapeutics Inc. (NASDAQ: RGLS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for RGLS provided by MarketBeat
Show more

StockNews.com 
0
Report Share
10.05.25 Sell -2.76%
Prediction Buy
Perf. (%) 373.15%
Target price 5.573
Change
Ends at 27.03.26

Regulus Therapeutics Inc. (NASDAQ: RGLS) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $6.00 price target on the stock, up previously from $3.00.
Ratings data for RGLS provided by MarketBeat
Show more

Wells Fargo & Company 
0
Report Share
27.03.25
Show more
Not a member yet? Sign up for free!